About: Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 2011 (uk) article scientifique publié en 2011 (fr) im Dezember 2011 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q57396240-D4436169-0263-454B-B71A-F61ADB1F834B
publication date	2011-12-06 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57396240-730F56A2-A549-4EE6-B06F-5966FA2ABC16
language of work or name	English
author name string	wds:Q57396240-17218132-FDE2-4412-A2FC-6288E778F0BF wds:Q57396240-1EE3C833-77B9-437E-AED0-1A731F73C344 wds:Q57396240-4C7046F6-6CA2-4D7E-A8D4-F9F49FBD9721 wds:Q57396240-600B8C7E-AC97-4685-B255-C63403666B0D wds:Q57396240-77F399F6-2776-42BA-938E-487989187998 wds:Q57396240-A582570B-1A8C-4C49-B110-E458D68E4AAF wds:Q57396240-D505FF3D-CC55-4527-9CD8-FE96A915F25B wds:Q57396240-E1664015-1E12-4610-84E2-40BD7780E968
author name string	Robert McKelvie John S. Gottdiener John J. McMurray Michael R. Zile Barry M. Massie Catalin F. Baicu Peter E. Carson Scott J. Hetzel
rdfs:label	Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction (en) Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction (nl)
skos:prefLabel	Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction (en) Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction (nl)
name	Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction (en) Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction (nl)
author	wds:Q57396240-79C7778B-C8F7-40D0-8309-C7881232CAFE
author	Michel Komajda
title	wds:Q57396240-F344B37E-9285-4A35-8564-EBB0106FE7A9
title	Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction (en)
page(s)	wds:Q57396240-420597BA-5EAC-4270-A425-01E704D2CFCC
page(s)	2491-2501
instance of	wds:Q57396240-495368F0-215A-4E68-AB41-7A70EAF3A645
instance of	scholarly article
main subject	wds:Q57396240-410316DE-49F8-4E16-9F25-77D38E2EB73C wds:Q57396240-443BCFBD-A1B3-46F6-830B-905E0EA8187A wds:Q57396240-850CE79D-9333-47BA-941F-92464E96759E
main subject	ejection fraction heart failure Patients
PubMed ID	wds:Q57396240-6AFD97FF-6B8A-410F-9EF9-6FAFFCBB9FFB
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22064591
PubMed ID	22064591
published in	wds:Q57396240-1F5C8D29-C933-4E7C-92B9-5D4524D0AC9E
published in	Circulation
issue	wds:Q57396240-48EFE14D-2051-4DD1-90D3-1F86E46CF811
volume	wds:Q57396240-9FC7A7F4-F862-45B7-BB39-12364B27724E
issue	23
volume	124
DOI	wds:Q57396240-62DDB23C-4526-42D7-9514-E78A5D3F9BB3
DOI	http://dx.doi.org/10.1161/CIRCULATIONAHA.110.011031
DOI	10.1161/CIRCULATIONAHA.110.011031
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57396240
is cites work of	Long-term effects of L- and N-type calcium channel blocker on uric acid levels and left atrial volume in hypertensive patients. Developing therapies for heart failure with preserved ejection fraction: current state and future directions Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation WHO's in second?: A practical review of World Health Organization group 2 pulmonary hypertension Heart failure with preserved ejection fraction Phosphorylation of cardiac Myosin-binding protein-C is a critical mediator of diastolic function Myosin cross-bridge dynamics in patients with hypertension and concentric left ventricular remodeling. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE? The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial. Heart failure with preserved ejection fraction in the elderly: scope of the problem Traffic-related air pollution and the right ventricle. The multi-ethnic study of atherosclerosis Heart failure with preserved ejection fraction: current understandings and challenges Preservation of myocardial fatty acid oxidation prevents diastolic dysfunction in mice subjected to angiotensin II infusion Higher number of live births is associated with left ventricular diastolic dysfunction and adverse cardiac remodelling among US Hispanic/Latina women: results from the Echocardiographic Study of Latinos High-intensity interval training: a review of its impact on glucose control and cardiometabolic health. Pulmonary hyperinflation and left ventricular mass: the Multi-Ethnic Study of Atherosclerosis COPD Study Mechanisms of diastolic dysfunction in heart failure with a preserved ejection fraction: If it's not one thing it's another Shortening of the elastic tandem immunoglobulin segment of titin leads to diastolic dysfunction Alternative Splicing of Titin Restores Diastolic Function in an HFpEF-Like Genetic Murine Model (TtnΔIAjxn) Pathological ventricular remodeling: mechanisms: part 1 of 2 Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure. Age- and sex-related differences in diastolic function and cardiac dimensions in a hypertensive population Histamine H2 Receptor Antagonists, Left Ventricular Morphology, and Heart Failure Risk: The MESA Study Tuning the molecular giant titin through phosphorylation: role in health and disease Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial. Sex differences in new-onset heart failure. Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial Diastolic stiffness as assessed by diastolic wall strain is associated with adverse remodelling and poor outcomes in heart failure with preserved ejection fraction Prevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction. The many faces of heart failure with preserved ejection fraction Management of Heart Failure with Preserved Ejection Fraction: Current Challenges and Future Directions Circulating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiology Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction. Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial Global longitudinal strain in patients with suspected heart failure and a normal ejection fraction: does it improve diagnosis and risk stratification?

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software